Q1 2019 · —
Revenue—
Net Income-$10.77M-$10.77M no prior Q1 2018 on file
EPS, diluted—
Operating Incomederived-$7,813—
Operating Cash Flowderived-$9,813—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
no prior Q1 2018 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Compass Therapeutics, Inc. · CIK 1738021 · Engraved from SEC EDGAR